Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)
Titel:
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)
Auteur:
Nathan, Paul Ascierto, Paolo A. Haanen, John Espinosa, Enrique Demidov, Lev Garbe, Claus Guida, Michele Lorigan, Paul Chiarion-Sileni, Vanna Gogas, Helen Maio, Michele Fierro, Maria Teresa Hoeller, Christoph Terheyden, Patrick Gutzmer, Ralf Guren, Tormod K. Bafaloukos, Dimitrios Rutkowski, Piotr Plummer, Ruth Waterston, Ashita Kaatz, Martin Mandala, Mario Marquez-Rodas, Ivan Muñoz-Couselo, Eva Dummer, Reinhard Grigoryeva, Elena Young, Tina C. Schadendorf, Dirk